Platinum Equity buys controlling stake in Inventia Healthcare's OSD arm

The acquisition of the Mumbai-headquartered pharmaceutical business was led by Platinum Equity's Asia investment team in Singapore.

Andrew Tjaardstra

August 30, 2024

US private equity (PE) firm Platinum Equity has acquired a controlling stake in Inventia Healthcare’s core Oral Solid Dosage (OSD) business from PE firm Invascent’s India Life Sciences Fund III, New York Life Investment Management's Jacob Ballas India Fund III and affiliates of the company's founding Shah family.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.